2005
DOI: 10.1097/01.rct.0000153956.33296.b5
|View full text |Cite
|
Sign up to set email alerts
|

Differentiation of Chronic Focal Pancreatitis From Pancreatic Carcinoma by In Vivo Proton Magnetic Resonance Spectroscopy

Abstract: Chronic focal pancreatitis and pancreatic carcinoma can be distinguished from each other by analysis of in vivo H-MR spectra, and in vivo H-MRS can be a useful method for making a differential diagnosis between chronic focal pancreatitis and pancreatic carcinoma.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
34
1
1

Year Published

2006
2006
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 68 publications
(36 citation statements)
references
References 46 publications
0
34
1
1
Order By: Relevance
“…With in vivo 1 H MRS technology, clinical research has concluded that lipid in chronic focal pancreatitis is significantly less than that observed in pancreatic carcinoma tissues (37). Cancerous tissues generally have high lipid content, but the reverse is not always true for other pancreatic diseases, as tissue lipid content varies widely due to factors such as genetics, aging, gender and the environment.…”
Section: Discussionmentioning
confidence: 99%
“…With in vivo 1 H MRS technology, clinical research has concluded that lipid in chronic focal pancreatitis is significantly less than that observed in pancreatic carcinoma tissues (37). Cancerous tissues generally have high lipid content, but the reverse is not always true for other pancreatic diseases, as tissue lipid content varies widely due to factors such as genetics, aging, gender and the environment.…”
Section: Discussionmentioning
confidence: 99%
“…From last few years its use has been tried in many other tumors including esophagus [18], colon [19], prostate [20], pancreas [21], breast [22] and cervix [23]. In MRS instead of detecting the magnetic resonance of water (as done in conventional MRI); various other chemical compounds are detected.…”
Section: Imaging Studies a Magnetic Resonance Spectroscopy (Mrs)mentioning
confidence: 99%
“…110 1 H MRS has also been used to study tumors of the breast, pancreas, cervix, and thyroid gland. 111 31 P MRS also has potential utility to noninvasively assess tumors. It has shown some promise to differentiate prostate carcinoma from benign prostatic hypertrophy.…”
Section: -108mentioning
confidence: 99%
“…Whole-body SSTR imaging is performed with radiolabeled derivatives of octreotide, which have a preference for subtype 2 SSTRs (ie, SSTR 2 ). The most commonly used agent is 111 In-pentetreotide for SPECT imaging, although SSTR-targeted tracers have also been developed for PET, including 68 Ga-DPhe1-Tyr3-octrotide ( 68 Ga-DOTATOC) and Gluc-Lys( Ga-DOTATOC in the assessment of neuroendocrine tumors. 77 …”
Section: Somatostatin Receptorsmentioning
confidence: 99%